Stock Market Analysis

• Best Buy’s stock has lost more than 45% over the past 12 months as demand for electronic products has declined• One notable difference between Best Buy and other big-box retailers is...

Netflix bulls have built buy narrative on company’s new advertising service, monetization of account sharing and superior content generation A lower-priced, ad-supported service could help...

Following the Kanye West scandal, Adidas shares plunged. But the stock has recovered all losses and rallied an additional 14% The company is plagued by serious operational and reputational problems on...

Off-price retailer TJX Companies has been an outlier in 2022. Shares are up 2.7% year-to-date, significantly outperforming the S&P 500 as well as most of its peers in the retail space. TJX remains...

Before we can assess what’s next, we must evaluate what we know. Last week (see here) we found for the NASDAQ 100 (NDX): “The Dow is now only 2% below [the August] high, while the NDX is...

Despite great earnings, Eni keeps trading at half the P/E multiple of its peers due to country/political risk Operationally, Eni is doing well but it doesn't have an edge on its competitors If...

DASH remains unprofitable, yet still has an enterprise value near $20 billion Skeptics argue the business model, over time, simply won’t be able to work But the opportunity here is huge, and...

Tech stocks have had a dismal year in 2022, leading the stock market lower.But a broad gauge of the tech universe, the NASDAQ Composite, has reached a critical support area… and all...

If inflation is cooling, you would never know from those retail sales numbers that came out yesterday. I’m not going to get into all the data, but the numbers were better than expected. One item...

Let’s kickstart things and conduct a quick thought experiment, shall we?Who is wealthier?Someone who works eighty hours per week and earns $450,000 per year, or… Someone who works 20...

Biogen stock is getting favorable ratings after successful trial results for its latest Alzheimer's treatment Lecanemab is Biogen's latest attempt to cure the disease after its failed rollout of...

Asian tech conglomerate Sea Ltd (NYSE:SE) reported solid results for its third quarter and said it would increase its focus on profitability. As a result, Sea stock price soared over 36% on Tuesday to...

A year after its initial public offering, RIVN stock has disappointed But, for the most part, the Rivian business is on track Cyclical, macroeconomic risks might deter most investors, while the rest...

ECB Vice President said bank must prioritize fight against high inflation RSI at ‘overbought’ levels on DAX, other indices No fresh major macro catalysts to excite bulls The sharp rally in...